blood-and-bone-conditions

The Biggest Biotech Wins of the Week

While most industry analysts had their hands full with recently released ASCO abstracts, a handful of clinical wins flew largely under the...

Is Idera's Sell-Off Premature?

Stock in Idera Pharmaceuticals tanked this week when Celgene announced that the FDA approved Otezla (apremilast) for psoriatic arthritis, a...

Why Rockwell Medical Shares Soared

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in...